Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/12/2003WO2002044423A3 Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
09/12/2003WO2002044420A3 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/12/2003WO2002038794A3 Cardiovascular disease diagnostic and therapeutic targets
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002031191A3 Dendritically amplified detection method
09/12/2003WO2002030256A9 Diagnostic indicator of thymic function
09/12/2003WO2002029015A9 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
09/12/2003WO2002027995A3 Method, system and computer program product for technical management and biocontrol of disease in animal production systems
09/12/2003WO2002018572A3 Membrane penetrating peptides and uses thereof
09/12/2003WO2002010454A3 Haplotypes of the alas2 gene
09/12/2003WO2002010401A9 18431 and 32374, human protein kinase family members and uses therefor
09/12/2003WO2002009726A9 Methods of treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds
09/12/2003WO2002008754A9 Spatially resolved enzyme-linked assay
09/12/2003WO2002004956A3 Method of identifying conformation-sensitive binding peptides and uses thereof
09/12/2003WO2001096597A3 High throughput screening of compounds for biological activity
09/12/2003WO2001094528A9 Visual-servoing optical microscopy
09/12/2003WO2001088200A3 Isolation of genes within sle-1b taht mediate a beak in immune tolerance
09/12/2003WO2001085989A9 Hypha-specific factors from candida albicans
09/12/2003WO2001071031A3 Carrier for gene detection and its use for detecting validity of interferon therapy
09/12/2003WO2001046693A3 Screening under isothermal denaturing conditions
09/12/2003CA2754415A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2754186A1 Labeling reagents and labeled targets, target labeling processes and other processes or using same in nucleic acid determinations and anaylses
09/12/2003CA2754185A1 Labeling reagents and labeled targets, target labeling processes and other processes or using same in nucleic acid determinations and analyses
09/12/2003CA2754041A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2753922A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2753910A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2674835A1 Real-time nucleic acid detection processes and compositions
09/12/2003CA2478722A1 Methods for detecting genome-wide sequence variations associated with a phenotype
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478493A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids
09/12/2003CA2478298A1 Microarrays of cellulose binding chimeric proteins and methods of use thereof
09/12/2003CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003CA2478022A1 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
09/12/2003CA2477953A1 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477856A1 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003CA2477761A1 Methods for detection of genetic disorders
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477611A1 Rapid analysis of variations in a genome
09/12/2003CA2477566A1 Cloning and characterization of slc26a7 and slc26a9 anion exchangers
09/12/2003CA2477400A1 Treatment for asthma or allergies
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2476410A1 Methods to increase or decrease bone density
09/12/2003CA2475690A1 Diagnostic method for glaucoma
09/12/2003CA2466220A1 Phage ligand sensor devices and uses thereof
09/12/2003CA2460212A1 Rapid and sensitive detection of cells and viruses
09/12/2003CA2421556A1 Real-time nucleic acid detection processes and compositions
09/11/2003US20030172408 Transcription factor stress-related polypeptides and methods of use in plants
09/11/2003US20030172400 Comprises nucleotide sequences coding anthocyanidin-rutinoside acyltransferase (AR-AT) for improving/increaseing flower varieties; horticulture
09/11/2003US20030172394 Selection and cloning methods
09/11/2003US20030172388 Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
09/11/2003US20030171878 Methods for the identification of genetic features for complex genetics classifiers
09/11/2003US20030171697 Tester for automated identification of analytes in bodily fluids
09/11/2003US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy
09/11/2003US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171335 Antisense antiviral agent and method for treating ssRNA viral infection
09/11/2003US20030171328 Non-invasive method for detecting target-RNA
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171320 Methods for treating ocular neovascular diseases
09/11/2003US20030171319 Human chemokine beta-10 mutant polypeptides
09/11/2003US20030171317 Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
09/11/2003US20030171315 Novel oligonucleotides comprising universal and/or generic bases, in particular juxtaposed universal and/or generic bases, which can be used to treat or prevent disease.
09/11/2003US20030171313 Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to
09/11/2003US20030171311 Compounds, including enzymatic nucleic acid molecules, ribozymes, DNAzymes, nuclease activating compounds and chimeras such as 2',5'-adenylates, that modulate the expression and/or replication of hepatitis C virus
09/11/2003US20030171295 Drug screening assays, and diagnostic and therapeutic methods for the treatment of body weight disorders, such as obesity, anorexia and cachexia, utilizing the melanocortin 4-receptor (MC4-R) as the target for intervention
09/11/2003US20030171291 Novel treatment
09/11/2003US20030171280 Compositions and methods for modulation of immune responses
09/11/2003US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1.
09/11/2003US20030171271 Therapeutic application in the treatment of conditions including cancer, macular degeneration and retinopathies. Also included are methods of treating a patient having a pathological condition characterized by an increase in
09/11/2003US20030171255 Modulating the phosphorylation of DARPP-32 in a serotonergic receptor intracellular signaling pathway. The invention provides methods and compositions for modulating the activities of DARPP-32, casein kinase 1 (CK1),
09/11/2003US20030171252 Nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for human
09/11/2003US20030170914 Replicable probe array
09/11/2003US20030170913 Manufacture of a microsensor device and a method for evaluating the function of a liquid by the use thereof
09/11/2003US20030170911 Non-oligomerizing fluorescent proteins
09/11/2003US20030170907 Immunoassay using lanthanide ions or their chelates as labels and dissociative fluorescence enhancement as a tool for detection where the enhancement solution comprises an aryl-carbonylmethylcarbonyl polyfluoroalkane; kinetics; stability
09/11/2003US20030170905 A particle comprising a chromogen, a peroxide, an enhancer, a stabilizer, and a binder, the chromogen being selected to react with occult blood to produce a visible and immediate color change; kitty litter; veterinary medicine
09/11/2003US20030170900 Deactivating and deleting a characteristic gene defining a detectable host characteristic and inserting a DNA fragment of interest into the modified host together with intact characteristic gene enabling confirmation of integration
09/11/2003US20030170895 Methods of making hypermutable cells using PMSR homologs
09/11/2003US20030170890 Produced by conversion of healthy myocardial cell by stimulation with hormones, hormone analogs and/or cytokines; used for detecting and identifying substances acting on the heart
09/11/2003US20030170882 Method of manufacturing a self-sealing chamber
09/11/2003US20030170875 Genetic mutation underlying orthostatic intolerance and diagnostic and therapeutic methods relating thereto
09/11/2003US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170858 Gyrase inhibitors and uses thereof
09/11/2003US20030170849 Tyrosylprotein sulfotransferases
09/11/2003US20030170842 Crystal proteins comprising proline substitutions; vapor diffusion; nuclear magnetic resonance; high resolution
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170838 Novel polynucleotides and polypeptides encoded thereby
09/11/2003US20030170812 Interleukin-1beta converting enzyme like cysteine protease
09/11/2003US20030170792 MAGE-3 peptides presented by HLA class ll molecules
09/11/2003US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170787 Isolated nucleic acid; insecticides
09/11/2003US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit
09/11/2003US20030170782 Proteins
1 ... 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 ... 3003